BOSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ...
Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. We are all swimming in an ocean of data. Every click, every ...
Databricks has added a new agent, the Data Science Agent, to the Databricks Assistant, in an effort to help data practitioners automate analytics tasks. The agent, which is available now in preview ...
ALLO-316 in advanced clear cell renal cell carcinoma (ccRCC): Updated results from the phase 1 TRAVERSE study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
Have you ever felt like your Excel skills hit a ceiling, no matter how many pivot tables you create? You’re not alone. While standard pivot tables are a reliable tool for summarizing data, they often ...
Your data is only as good as how you interpret it. Fueled by the promise of concrete insights, organizations are increasingly prioritizing data in their decision-making processes. But that process can ...
When you’re a data scientist, you kind of get used to things moving at the speed of light. For recent graduates of the University of Delaware Graduate College’s interdisciplinary data science master’s ...
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H AI-powered HER2 quantification continuous score (QCS) and tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results